Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

QuidelOrtho Corporation - Common Stock (NQ:QDEL)

28.96 +0.87 (+3.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about QuidelOrtho Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
3 Dawdling Stocks with Mounting Challenges
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
3 Value Stocks That Concern Us
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - imaging, diagnostics stocks... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Medical Devices & Supplies - Imaging, Diagnostics Stocks Q4 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including QuidelOrtho (NASDAQ:QDEL) and its... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why QuidelOrtho Stock Bounced More Than 4% Higher Today
Via The Motley Fool
Where QuidelOrtho Stands With Analysts
Via Benzinga
1 Stock Under $50 with Exciting Potential and 2 to Brush Off
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
Q4 Earnings Review: Medical Devices & Supplies - Imaging, Diagnostics Stocks Led by GE HealthCare (NASDAQ:GEHC)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at GE HealthCare (NASDAQ:GEHC) and its peers. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including Lantheus (NASDAQ:LNTH) and its... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Earnings Scheduled For February 12, 2025
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For QuidelOrtho
Via Benzinga
3 Reasons to Avoid QDEL and 1 Stock to Buy Instead
Over the last six months, QuidelOrtho’s shares have sunk to $40.10, producing a disappointing 7.7% loss - a stark contrast to the S&P 500’s 7.1% gain. This was partly due to its softer quarterly... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Earnings To Watch: Lantheus (LNTH) Reports Q4 Results Tomorrow
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings tomorrow before market hours. Here’s what you need to know. 
Via StockStory
Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings
Medical device company Penumbra (NYSE:PEN) will be reporting earnings tomorrow afternoon. Here’s what you need to know. 
Via StockStory
QuidelOrtho’s (NASDAQ:QDEL) Q4: Beats On Revenue But Full-Year Sales Guidance Misses Expectations
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q4 CY2024 results topping the market’s revenue expectations, but sales fell by 4.7% year on year to $707.8 million. On the other hand,... 
Via StockStory
Exposures COVID-19
QuidelOrtho Earnings: What To Look For From QDEL
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be announcing earnings results tomorrow afternoon. Here’s what to expect. 
Via StockStory
Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted
QuidelOrtho's secondary offering of 8.26 million shares is priced at $38.58, removing an investor overhang, according to William Blair's analysis. 
Via Benzinga
Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Why Keysight Technologies Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Top 4 Health Care Stocks That May Plunge This Quarter
Via Benzinga
Smaller Cap Biotechs Are In Season: How Are We Doing?
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
A Biotech Breakout Will Be Led By Small Caps
It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever. 
Via Talk Markets
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Why QuidelOrtho Stock Blasted 10% Higher Today
The healthcare company has significant and untapped earnings potential, asserts one pundit. 
Via The Motley Fool
G-III Apparel Posts Upbeat Results, Joins NIO, Yext, Shoe Carnival And Other Big Stocks Moving Higher On Thursday
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
QDEL Stock Earnings: QuidelOrtho Misses EPS, Beats Revenue for Q1 2024
QDEL stock results show that QuidelOrtho missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
What's Going With COVID-19 Test Maker QuidelOrtho Stock On Tuesday?
QuidelOrtho secures FDA approval for QuickVue COVID-19 test, catering to home and medical settings. Despite Savanna RVP4+ assay withdrawal, company promises a new multiplex assay for 2024/2025... 
Via Benzinga
Exposures COVID-19 Product Safety
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. 
Via Benzinga
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.